USPTO serial 87699112
GYROSCOPE
Reviewed by CopyMark Law Group
Reg. 5652807Status 710
- Filing date
- Status date
- Registration date
- Jan 15, 2019
- Examiner
- WATTS-FITZGERALD, CAITLIN C
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with GYROSCOPE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Gyroscope Therapeutics Limited
Stevenage, Herts, GB
Gyroscope Therapeutics Limited
Stevenage, Herts, GB
Gyroscope Therapeutics Limited
Stevenage, Herts, GB
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Maury M. Tepper, III
Maury M. Tepper, III Tepper & Eyster, PLLC3724 BENSON DRRALEIGH, NC 27609UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Medical and veterinary preparations for therapeutic purposes, namely, for the prevention and treatment of age-related macular degeneration, geographic atrophy and other ophthalmological diseases and disorders; pharmaceutical preparations for gene therapy, namely, nucleic acids, viral and non-viral vectors; biologic preparations for medical purposes, namely, biological preparations for the prevention and treatment of age-related macular degeneration, geographic atrophy and other eye diseases; biologic preparations for use in treatment of genetically based diseases and disorders, namely, age-related macular degeneration, geographic atrophy and other ophthalmological diseases and disorders; biologic preparations for use in the treatment of ophthalmological diseases and disorders; biologic preparations for use in the treatment of blinding diseases and disorders; biologic preparations for use in the treatment of complement pathway-related or complement pathway-mediated diseases or disorders; gene therapy preparations in the nature of nucleic acids and viral vectors for use in treatment of genetically based diseases and disorders; gene therapy preparations in the nature of nucleic acids and viral vectors for medical purposes; gene therapy preparations in the nature of nucleic acids and viral vectors for use in the treatment of ophthalmological diseases and disorders; gene therapy preparations in the nature of nucleic acids and viral vectors for use in the treatment of blinding diseases and disorders; gene therapy preparations in the nature of nucleic acid and viral vectors for use in the treatment of complement pathway-related or complement pathway-mediated diseases or disorders | SECTION 8 - CANCELLED | — |
| 010 | Medical and veterinary apparatus and instruments for ocular surgery; ophthalmic apparatus and instruments, namely, surgical apparatus for use in ophthalmic surgery; apparatus and instruments for treating the eye, namely, cannulas and needles for obtaining sub-retinal access; apparatus and instruments for dispensing or delivering preparations into the eye or structures thereof, namely, cannulas and needles for the delivery and administration of gene therapy preparations, to the eye for the treatment of eye conditions; apparatus and instruments for performing eye surgery, namely, cannulas and needles; parts and fittings for the aforesaid goods | SECTION 8 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Gyroscope Therapeutics Limited
- Other trademarks owned by Gyroscope Therapeutics Limited
- Other trademarks owned by Gyroscope Therapeutics Limited
- Other trademarks in Class 005
- Other trademarks in Class 010
- Similar marks named GYROSCOPE
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 25, 2025 | C8.. | CANCELLED SEC. 8 (6-YR) | — |
| Jan 15, 2024 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Aug 31, 2022 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Aug 31, 2022 | EWAF | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | — |
| Aug 31, 2022 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 31, 2022 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Apr 1, 2022 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Apr 1, 2022 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Apr 1, 2022 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Apr 1, 2022 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 1, 2022 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Apr 1, 2022 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Jan 15, 2019 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Oct 30, 2018 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Oct 30, 2018 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Oct 10, 2018 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Sep 27, 2018 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Sep 25, 2018 | ALIE | ASSIGNED TO LIE | — |
| Sep 12, 2018 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 11, 2018 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 11, 2018 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 11, 2018 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 12, 2018 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 12, 2018 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 12, 2018 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 12, 2018 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 7, 2017 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 1, 2017 | NWAP | NEW APPLICATION ENTERED | — |